What does Europe have to gain from an innovative, research-based pharmaceutical industry? And what challenges is the industry facing? By Brian Ager, Director General of the European Federation of Pharmaceutical Industries and Associations EFPIA.
In their quest to be innovative, pharmaceutical and biotechnological companies are applying their own strategies in response to the growing demands for improvement, creative ideas, breakthrough technologies and new medicines.
Martin Terberger, Head of Unit, Pharmaceuticals, Directorate General, Enterprise and Industry outlines the European Commission’s view on pharma moving forward.
The pharmaceutical business – once the envy of fellow industries for its year-on-year surging profits – has suddenly found itself staring at a crisis.
Introduction GFC Transfection Arrays are a novel screening tool to identify key functional genes in a biological pathway.